Denis Drygin serves as Executive at Regulus Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Denis Drygin has executed 2 insider transactions totaling $23.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 1, 2022 involved purchasing 76,686 shares valued at $17.6K.
Denis Drygin currently holds 100,000 shares of Regulus Therapeutics Inc. (RGLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Denis Drygin has been a net buyer of RGLS stock. They have purchased $23.0K and sold $0 worth of shares.
Denis Drygin's most recent insider trade was on Mar 1, 2022, when they purchased 76,686 shares at $0.23 per share.
Get notified when new Form 4 filings are submitted
| $0.23 |
| Discretionary |